Q
Qiuhua Deng
Researcher at Guangzhou Medical University
Publications - 38
Citations - 1380
Qiuhua Deng is an academic researcher from Guangzhou Medical University. The author has contributed to research in topics: Lung cancer & Adenocarcinoma. The author has an hindex of 14, co-authored 31 publications receiving 1105 citations. Previous affiliations of Qiuhua Deng include Wenzhou Medical College.
Papers
More filters
Journal ArticleDOI
Development and Validation of a Nomogram for Predicting Survival in Patients With Resected Non–Small-Cell Lung Cancer
Wenhua Liang,Li Zhang,Gening Jiang,Qun Wang,Lunxu Liu,Deruo Liu,Zheng Wang,Zhihua Zhu,Qiuhua Deng,Xinguo Xiong,Wenlong Shao,Xiaoshun Shi,Jianxing He +12 more
TL;DR: A novel nomogram is established and validated that can provide individual prediction of OS for patients with resected NSCLC and may help clinicians in decision making and design of clinical studies.
Journal ArticleDOI
A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies
Johannes R. Kratz,Jianxing He,Stephen K. Van Den Eeden,Zhihua Zhu,Wen Gao,Patrick Pham,Michael S. Mulvihill,Fatemeh Ziaei,Huanrong Zhang,Bo Su,Xiuyi Zhi,Charles P. Quesenberry,Laurel A. Habel,Qiuhua Deng,Zongfei Wang,Jiangfen Zhou,Huiling Li,Mei-Chun Huang,Che-Chung Yeh,Mark R. Segal,M. Roshni Ray,Kirk D. Jones,Dan J. Raz,Zhidong Xu,Thierry Jahan,David Berryman,Biao He,Michael J. Mann,David M. Jablons +28 more
TL;DR: A practical, quantitative-PCR-based assay reliably identified patients with early-stage non-squamous NSCLC at high risk for mortality after surgical resection and improved prognostic accuracy beyond National Comprehensive Cancer Network criteria for stage I high-risk tumours.
Journal ArticleDOI
Frequent alterations in cytoskeleton remodelling genes in primary and metastatic lung adenocarcinomas.
Kui Wu,Xin Zhang,Fuqiang Li,Dakai Xiao,Yong Hou,Shida Zhu,Dongbing Liu,Xiaofei Ye,Mingzhi Ye,Jie Yang,Shao Libin,Hui Pan,Na Lu,Yuan Yu,Liping Liu,Jin Li,Liyan Huang,Hailing Tang,Qiuhua Deng,Zheng Yue,Lihua Peng,Geng Liu,Xia Gu,Ping He,Yingying Gu,Weixuan Lin,Huiming He,Guoyun Xie,Han Liang,Na An,Hui Wang,Manuel R. Teixeira,Joana Vieira,Wenhua Liang,Xin Zhao,Zhiyu Peng,Feng Mu,Xiuqing Zhang,Xun Xu,Huanming Yang,Karsten Kristiansen,Jian Wang,Nanshan Zhong,Jun Wang,Qiang Pan-Hammarström,Jianxing He +45 more
TL;DR: This study represents the first large-scale sequencing effort on lung adenocarcinoma in Asian patients and provides a comprehensive mutational landscape for both primary and metastatic tumours, and may form a basis for personalized medical care.
Journal ArticleDOI
Oncogenic driver mutations in patients with non-small-cell lung cancer at various clinical stages
Jeff X. Zhou,Haihong Yang,Qiuhua Deng,Xia Gu,Ping He,Yunen Lin,Meiling Zhao,Juhong Jiang,H. Chen,W. Yin,L. Mo,Jianxing He +11 more
TL;DR: EML4-ALK fusions could serve as a significant prognostic indicator for locally advanced NSCLC and had significantly higher levels of ERCC1, a molecule with a key role in platinum drug efficacy, than tumors without E ML4-alk fusions.
Journal ArticleDOI
MicroRNA-26a/b regulate DNA replication licensing, tumorigenesis, and prognosis by targeting CDC6 in lung cancer.
Xin Zhang,Dakai Xiao,Ziyi Wang,Yongxin Zou,Liyan Huang,Weixuan Lin,Qiuhua Deng,Hui Pan,Jiangfen Zhou,Chun Liang,Jianxing He +10 more
TL;DR: It is demonstrated that miR 26a and miR26b inhibit replication licensing and the proliferation, migration, and invasion of lung cancer cells by targeting CDC6.